SavedAdd your journal

Journals / Anadolu Psikiyatri Dergisi / 2015 / Cilt: 16 - Sayı: 4

Olanzapinle tedavi edilen bir iki uçlu bozukluk hastasında huzursuz bacaklar sendromu: Bir ilişki var mı?

Restless legs syndrome in a bipolar disorder patient treated with olanzapine: is there an association?

ŞADİYE VİSAL BUTURAK
Duygu TİRYAKİ
Ersel DAĞ
Yakup TÜRKEL
Pages
301–303
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

To our knowledge there are no studies about the association between BD and RLS and further research are needed on this subject. (Anatolian Journal of Psychiatry 2015; 16(4):301-303)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this case report is to report a case of restless legs syndrome (RLS) in a patient with bipolar disorder (BD) caused by olanzapine and to draw attention to possible relationship between BD and RLS.
📊
Key Findings & Data:Olanzapine 10 mg/day was added to the extended release valproic acid 1000 mg/d treatment that the patient was using.
💡
Conclusion & Impact:To our knowledge there are no studies about the association between BD and RLS and further research are needed on this subject. (Anatolian Journal of Psychiatry 2015; 16(4):301-303)
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

The aim of this case report is to report a case of restless legs syndrome (RLS) in a patient with bipolar disorder (BD) caused by olanzapine and to draw attention to possible relationship between BD and RLS. A female patient was diagnosed with mixed episode of BD. Olanzapine 10 mg/day was added to the extended release valproic acid 1000 mg/d treatment that the patient was using. In the next day after the beginning of olanzapine, itching, aching and tingling sensations begun in her legs at rest. She was diagnosed as RLS caused by olanzapine. Then the dose of olanzapine gradually reduced. But the symptoms were continuing at the dose of 2.5 mg/day. RLS symptoms disappeared in the next day after discontinuation of olanzapine. RLS has comorbidity with some psychiatric and neurologic disorders such as attention deficit/hyperactivity disorder (ADHD), depressive disorders, migraine. There are studies that showed genetic relationship between BD and both migraine and ADHD. As a result there might be an association between BD and RLS. These may account for the appearance of RLS with low dose olanzapine in this case. To our knowledge there are no studies about the association between BD and RLS and further research are needed on this subject. (Anatolian Journal of Psychiatry 2015; 16(4):301-303)

Özet

Bu olgu sunumunun amacı iki uçlu bozukluğu (İUB) olan bir hastada olanzapinin neden olduğu huzursuz bacaklar sendromu (HBS) olgusunu bildirmek ve İUB ile HBS arasındaki olası ilişkiye dikkat çekmektir. Bir kadın hastaya İUB karma atak tanısı konuldu. Hastanın kullanmakta olduğu uzun salınımlı valproik asid 1000 mg/gün tedavisine 10 mg/gün olanzapin eklendi. Olanzapin başlandıktan sonraki gün dinlenme sırasında hastanın bacaklarında kaşın- ma, ağrı ve karıncalanma hissi başladı. Hastaya olanzapine bağlı HBS tanısı konuldu. Olanzapin dozu kademeli olarak azaltıldı. Ancak 2.5 mg/gün dozunda belirtiler sürüyordu. Olanzapin kesildikten bir gün sonra HBS belirtileri düzeldi. HBS, dikkat eksikliği hiperaktivite bozukluğu (DEHB), depresif bozukluklar, migren gibi bazı psikiyatrik ve nörolojik bozukluklarla birlikte görülebilir. İUB ile hem migren, hem de DEHB arasında genetik ilişki olduğunu gösteren çalışmalar vardır. Sonuç olarak İUB ve HBS arasında bir ilişki olabilir. Bizim bilgimize göre İUB ve HBS arasındaki ilişki ile ilgili çalışma yoktur ve bu konu ile ilgili ileri araştırmalara gerek vardır. (Anadolu Psikiyatri Derg 2015; 16(4):301-303)

🔖

Cite This Article

BUTURAK, Ş. V., TİRYAKİ, D., DAĞ, E., TÜRKEL, Y. (2015). Olanzapinle tedavi edilen bir iki uçlu bozukluk hastasında huzursuz bacaklar sendromu: Bir ilişki var mı?. Anadolu Psikiyatri Dergisi, Cilt: 16 - Sayı: 4, 301–303. https://ajindex.com/articles/210661

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ondo WG, Jancovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology 1996; 47(6):1435-1441
  2. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly. Neurology 2000; 54(5):1064-1068
  3. Gkizlis V, Giannaki CD, Karatzaferi C, Hadjigeor- giou GM, Mihas C, Koutedakis Y, et al. Uremic versus ıdiopathic restless legs syndrome: ımpact on aspects related to quality of life. ASAIO J 2012; 58(6):607-611
  4. Sethi KD, Mehta SH. A clinical primer on restless legs syndrome: what we know, and what we don't know. Am J Manag Care 2012; 18(5):83-88
  5. Duggal HS, Mendhekar DN. Clozapine-associ- ated restless legs syndrome. J Clin Psychophar- macol 2007; 27(1):89-90
  6. Horiguchi J, Yamashita H, Mizuno S, Kuramoto Y, Kagaya A, Yamawaki S, et al. Nocturnal eating/ drinking syndrome and neuroleptic-induced rest- less legs syndrome. Int Clin Psychopharmacol 1999; 14(1):33-36
  7. Aggarwal S, Dodd S, Berk M. Restless leg syn- drome associated with olanzapine: a case series. Curr Drug Saf 2010; 5(2):129-131
  8. Buturak SV, Yazici K, Yazici AE, Tot S, Basterzi AD. Restless legs syndrome in an elderly patient induced by combined use of low dose quetiapine and citalopram. Bulletin of Clinical Psychophar- macology 2012; 22(3):271-274
  9. Wetter TC, Brunner J, Bronisch T. Restless legs syndrome probably induced by risperidone treat- ment. Pharmacopsychiatry 2002; 35(3):109-111
  10. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syn- drome: diagnostic criteria, special considerations, and epidemiology. A report from the restless leg syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med 2003; 4(2):101-119
  11. Buchfuhrer MJ. Strategies for the Treatment of Restless Legs Syndrome. Neurotherapeutics 2012; 9(4):776-790
  12. Eisensehr I, Ehrenberg BL, Rogge Solti S, Noachtar S. Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/bensera- zid. J Neurol 2004; 251(5):579-583
  13. Haslemo T, Olsen K, Lunde H, Molden E. Valproic Acid significantly lowers serum concentrations of olanzapine-an interaction effect comparable with smoking. Ther Drug Monit 2012; 34(5):512-517
  14. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions